Literature DB >> 2558045

Four factors are required for 3'-end cleavage of pre-mRNAs.

Y Takagaki1, L C Ryner, J L Manley.   

Abstract

We reported previously that authentic polyadenylation of pre-mRNAs in vitro requires at least two factors: a cleavage/specificity factor (CSF) and a fraction containing nonspecific poly(A) polymerase activity. To study the molecular mechanisms underlying 3' cleavage of pre-mRNAs, we fractionated CSF further and show that it consists of four separable subunits. One of these, called specificity factor (SF; Mr, approximately 290,000), is required for both specific cleavage and for specific polyadenylation and thus appears responsible for the specificity of the reaction. Although SF has not been purified to homogeneity, several lines of evidence suggest that it may not contain an essential RNA component. Two other factors, designated cleavage factors I (CFI; Mr, approximately 130,000) and II (CFII; Mr, approximately 110,000), are sufficient to reconstitute accurate cleavage when mixed with SF. A fourth factor, termed cleavage stimulation factor (CstF; Mr, approximately 200,000), enhances cleavage efficiency significantly when added to a mixture of the three other factors. CFI, CFII, and CstF do not contain RNA components, nor do they affect specific polyadenylation in the absence of cleavage. Although these four factors are necessary and sufficient to reconstitute efficient cleavage of one pre-RNA tested, poly(A) polymerase is also required to cleave several others. A model suggesting how these factors interact with the pre-mRNA and with each other is discussed.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2558045     DOI: 10.1101/gad.3.11.1711

Source DB:  PubMed          Journal:  Genes Dev        ISSN: 0890-9369            Impact factor:   11.361


  98 in total

1.  Recruitment of a basal polyadenylation factor by the upstream sequence element of the human lamin B2 polyadenylation signal.

Authors:  S Brackenridge; N J Proudfoot
Journal:  Mol Cell Biol       Date:  2000-04       Impact factor: 4.272

2.  Unpaired terminal nucleotides and 5' monophosphorylation govern 3' polyadenylation by Escherichia coli poly(A) polymerase I.

Authors:  Y Feng; S N Cohen
Journal:  Proc Natl Acad Sci U S A       Date:  2000-06-06       Impact factor: 11.205

3.  Complex protein interactions within the human polyadenylation machinery identify a novel component.

Authors:  Y Takagaki; J L Manley
Journal:  Mol Cell Biol       Date:  2000-03       Impact factor: 4.272

Review 4.  Formation of mRNA 3' ends in eukaryotes: mechanism, regulation, and interrelationships with other steps in mRNA synthesis.

Authors:  J Zhao; L Hyman; C Moore
Journal:  Microbiol Mol Biol Rev       Date:  1999-06       Impact factor: 11.056

5.  Association of polyadenylation cleavage factor I with U1 snRNP.

Authors:  Sita Awasthi; James C Alwine
Journal:  RNA       Date:  2003-11       Impact factor: 4.942

6.  Regulated adenovirus mRNA 3'-end formation in a coupled in vitro transcription-processing system.

Authors:  S I Wilson-Gunn; J E Kilpatrick; M J Imperiale
Journal:  J Virol       Date:  1992-09       Impact factor: 5.103

7.  Separation of factors required for cleavage and polyadenylation of yeast pre-mRNA.

Authors:  J Chen; C Moore
Journal:  Mol Cell Biol       Date:  1992-08       Impact factor: 4.272

8.  Balanced efficiencies of splicing and cleavage-polyadenylation are required for mu-s and mu-m mRNA regulation.

Authors:  M L Peterson
Journal:  Gene Expr       Date:  1992

9.  Potential role of poly(A) polymerase in the assembly of polyadenylation-specific RNP complexes.

Authors:  M P Terns; S T Jacob
Journal:  Nucleic Acids Res       Date:  1991-01-25       Impact factor: 16.971

10.  The upstream sequence element of the C2 complement poly(A) signal activates mRNA 3' end formation by two distinct mechanisms.

Authors:  A Moreira; Y Takagaki; S Brackenridge; M Wollerton; J L Manley; N J Proudfoot
Journal:  Genes Dev       Date:  1998-08-15       Impact factor: 11.361

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.